Business Context and Reporting Period
Company: Compugen Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Second Quarter ended June 30, 2026 (Six months ended June 30, 2026)
Filing Date: August 3, 2026
This filing serves as a conduit to incorporate by reference the Company's press release, unaudited interim consolidated financial statements, and Management's Discussion and Analysis (MD&A) for the period. The primary financial data is contained in Exhibits 99.1, 99.2, and 99.3, which are not fully reproduced in the text of this Form 6-K.
Key Financial Metrics
The text of this Form 6-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are located in the incorporated exhibits (Exhibit 99.2 and 99.3) referenced within the filing.
- Revenue: Not stated in filing text.
- Net Income/Loss: Not stated in filing text.
- Cash Flow: Not stated in filing text.
- Debt and Liquidity: Not stated in filing text.
Material Changes
The filing text does not detail specific material changes versus the prior comparable period. It references the inclusion of comparative financial data for the six months ended June 30, 2025, within the incorporated exhibits, but does not summarize the variances in the body of this document.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates quotes attributable to Eran Ophir, Ph.D., from the press release (Exhibit 99.1), but the specific content of these quotes is not included in the text of this Form 6-K.
Guidance and Outlook: No specific forward-looking guidance or outlook is provided in the text of this filing.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this filing; such disclosures are expected to be found in the incorporated MD&A (Exhibit 99.3).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific commentary from Eran Ophir, Ph.D., and high-level financial highlights.
- Examine Exhibit 99.2 for the unaudited interim consolidated balance sheets, statements of comprehensive loss, and cash flows to verify actual revenue, loss, and liquidity positions.
- Analyze Exhibit 99.3 (MD&A) for detailed explanations of operational results, material changes, and risk factors.
- Confirm the incorporation by reference into the Company's Registration Statement on Form F-3 (File No. 333-295989).